SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-040713
Filing Date
2014-05-21
Accepted
2014-05-21 16:10:29
Documents
4
Period of Report
2014-05-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-12968_38k.htm 8-K 24756
2 EX-99.1 a14-12968_3ex99d1.htm EX-99.1 191759
3 GRAPHIC g129683mmi001.jpg GRAPHIC 25838
4 GRAPHIC g129683mmi002.gif GRAPHIC 9934
  Complete submission text file 0001104659-14-040713.txt   267268
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 14860852
SIC: 2834 Pharmaceutical Preparations